Quantcast

Latest Alzheimer's disease Stories

2014-07-08 12:28:10

DUBLIN, July 8, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/24nt73/global) has announced the addition of the "Global Alzheimer's Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Alzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65 years or above and...

2014-07-08 10:03:49

King's College London Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer's, marking a significant step towards developing a blood test for the disease Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer's, marking a significant step towards developing a blood test for the disease. The study, led by King's College London and UK proteomics company, Proteome Sciences plc, analysed over...

2014-07-08 08:31:42

ICA Provides a Breakthrough in Affordable, High-Quality Dementia Care MAPLETON, Maine, July 8, 2014 /PRNewswire/ -- The newly formed International Caregivers Association (ICA) has created a revolutionary dementia-care program that will reduce the cost of caring for patients with Alzheimer's disease and other dementias while simultaneously improving their quality of life. Now the association is sharing this program so caregivers around the world can learn highly effective techniques they can...

2014-07-08 08:30:45

Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on diagnosis and management INDIANAPOLIS, July 8, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that 23 presentations will be given at the Alzheimer's Association International Conference 2014 (AAIC 2014) in Copenhagen, Denmark from July 12 - 17, 2014. Of particular interest...

2014-07-03 12:39:55

Cleveland Clinic Analysis of clinical trials shows pipeline for therapeutics is small; 99.6 percent of drug attempts fail Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. The paper, "Alzheimer's Disease Drug Development...

2014-07-02 23:03:21

MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas, Texas (PRWEB) July 02, 2014 Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, it still remains a significant area of unmet medical need. Clinical success has...

2014-07-01 16:27:12

LONDON, July 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Alzheimer%s Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_alzheimer_s_drugs_market_2012_2016.html About Alzheimer's DiseaseAlzheimer's disease is a progressive, irreversible degeneration of the brain that disrupts the thinking, language, behavioral and cognitive skills of a person. AD is more prevalent in people aged 65 years or above and...

2014-07-01 12:29:01

ATLANTA, July 1, 2014 /PRNewswire-USNewswire/ -- Second Wind Dreams® (SWD®) announces the re-launch of its Family Edition of the Virtual Dementia Tour® (VDT®). This scientifically proven method builds sensitivity and awareness in individuals by temporarily altering participants' physical and sensory abilities with props and circumstances, which simulate changes associated with the physical and cognitive impairments of aging. Founder of Second Wind Dreams and inventor of the...

2014-07-01 11:36:25

Duke-NUS Graduate Medical School Singapore Researchers at Duke-NUS Graduate Medical School Singapore (Duke-NUS) have found evidence that the less older adults sleep, the faster their brains age. These findings, relevant in the context of Singapore's rapidly ageing society, pave the way for future work on sleep loss and its contribution to cognitive decline, including dementia. Past research has examined the impact of sleep duration on cognitive functions in older adults. Though faster...

2014-06-30 12:31:45

NEW YORK, June 30, 2014 /PRNewswire/ -- Oligomerix, Inc., a privately held company pioneering the development of disease modifying therapeutics for Alzheimer's disease (AD) and related neurodegenerative disorders, announced today the company will be presenting its lead drug development program during both the 9(th) Federation of European Neuroscience Societies (FENS) Forum of Neuroscience to be held July 5 - 9, 2014, in Milan, Italy and at the Alzheimer's Association International...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related